Comment on "A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study"

Hamidreza Majidiani^{1

2}, Seyyed Amir Hosseini³

Affiliations

¹ Healthy Aging Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran.
² Department of Basic Medical Sciences, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran.
³ Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Hamidreza Majidiani et al. Iran J Parasitol. 2024 Oct-Dec.

. 2024 Oct-Dec;19(4):515-516.

doi: 10.18502/ijpa.v19i4.17175.

Hamidreza Majidiani^{1

2}, Seyyed Amir Hosseini³

¹ Healthy Aging Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran.
² Department of Basic Medical Sciences, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran.
³ Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare none.

1. Pirmoradi S, Khadem MD, Monjezi Z, Bahrami S, Nzelu CO. A new immunogenic structure of polyepitopic fusion against Leishmania major : In silico study. Iran J Parasitol. 2024;19:290–304. - PMC - PubMed
1. Dunning N. Leishmania vaccines: From leishmanization to the era of DNA technology. Bioscience Horizons. 2009;2:73–82.
1. Basmenj ER, Arastonejad M, Mamizadeh M, et al. Engineering and design of promising t-cell-based multi-epitope vaccine candidates against leishmaniasis. Sci Rep. 2023;13(1):19421. - PMC - PubMed
1. Scott P, Novais FOJNRI. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat Rev Immunol. 2016;16:581–592. - PubMed
1. Scott P, Novais FO. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis. Nat Rev Immunol. 2016;16:581–592. - PubMed